Phase 3
Completed N=110
Antioxidant Supplementation in Pregnant Women
Pregnant Women · Preeclampsia
Source: ClinicalTrials.gov NCT01232205 ↗
Enrolled (actual)
110
Serious AEs
—
Results posted
Dec 2010
Primary outcomePrimary: Preeclampsia
Summary
The purpose of this study is to investigate the benefit of several micro nutrients of antioxidants (using milk) in a cohort of women with low antioxidant status and the changes in cell-free mRNA.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Preeclampsia |
1; 8 | — |
| SECONDARY Cell-free mRNA |
— | — |
Eligibility Criteria
Inclusion Criteria
- pregnant women with 8-12 weeks of gestation
Exclusion Criteria
- known multiple pregnancy
- known fetal anomaly
- known thrombophilia
- known infections and mola hydatidosa
- chronic renal failure
- uncontrolled hypertension
- known placental abnormalities
- documented uterine bleeding within a week of screening
- uterine malformation
- history of medical and metabolic complication such as heart disease or diabetes
Data sourced from ClinicalTrials.gov (NCT01232205). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.